11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Two distinct classes of degenerative change are independently linked to clinical progression in Mild Cognitive Impairment

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We previously demonstrated two statistically distinct factors of degeneration in Alzheimer’s disease (AD): one strongly related to white matter damage and age interpreted as ‘age- and vascular-related’, and the other related to cortical atrophy thought to represent ‘neurodegenerative changes associated with AD’. Those factors are now replicated in a distinct cross-sectional dataset of 364 participants from the Alzheimer’s Disease Neuroimaging Initiative and their interpretation is improved using correlations with CSF biomarkers. Furthermore, we now show that changes in both factors over two years are independently associated with decline in Mini-Mental State Examination (MMSE) score in a longitudinal subset of 116 individuals with mild cognitive impairment. Progression in the ‘age- and vascular-related’ factor was greater for individuals with two APOE ε 4 alleles and linked to a greater attributable change in MMSE than the ‘neurodegenerative’ factor. These results suggest benefits of targeting white matter and vascular health to complement interventions focused on the neurodegenerative aspect of the disease, even in individuals with little discernable vascular comorbidity.

          Related collections

          Author and article information

          Journal
          8100437
          6047
          Neurobiol Aging
          Neurobiol. Aging
          Neurobiology of aging
          0197-4580
          1558-1497
          9 May 2017
          16 February 2017
          June 2017
          01 June 2018
          : 54
          : 1-9
          Affiliations
          [a ]MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
          [b ]Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA
          [c ]Departments of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
          [d ]Neuroimaging Research for Veterans Center, VA Boston Healthcare System, Boston, MA, USA
          Author notes
          Corresponding author: Jean-Philippe Coutu; coutu@ 123456nmr.mgh.harvard.edu ; Address: Athinoula A. Martinos Center for Biomedical Imaging, 149 13 th Street, Room 2301, Charlestown, MA 02129, USA; Phone: 1-857-318-9617; Fax: 1-617-726-7422
          [†]

          Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuro-imaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf

          [1]

          Biospective Inc, Montreal, Canada

          [2]

          Computer Vision Laboratory, ETH Zurich, Switzerland

          Article
          PMC5519085 PMC5519085 5519085 nihpa852494
          10.1016/j.neurobiolaging.2017.02.005
          5519085
          28286328
          f56604f4-cccd-4c63-9bb6-f5d7952c6c2d
          History
          Categories
          Article

          mild cognitive impairment,White matter,longitudinal cohort study,cognitive decline,Alzheimer’s disease,small-vessel disease,CSF biomarkers

          Comments

          Comment on this article